T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.

MLA

Behar, Mark, et al. “T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.” AJNR. American Journal of Neuroradiology, vol. 44, no. 12, Dec. 2023, pp. 1451–57. EBSCOhost, https://doi.org/10.3174/ajnr.A8057.

APA

Behar, M., Peck, K. K., Yildirim, O., Tisnado, J., Saha, A., Arevalo-Perez, J., Lis, E., Yamada, Y., Holodny, A. I., & Karimi, S. (2023). T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy. AJNR. American Journal of Neuroradiology, 44(12), 1451–1457. https://doi.org/10.3174/ajnr.A8057

Chicago

Behar, Mark, Kyung K Peck, Onur Yildirim, Jamie Tisnado, Atin Saha, Julio Arevalo-Perez, Eric Lis, Yoshiya Yamada, Andrei I Holodny, and Sasan Karimi. 2023. “T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.” AJNR. American Journal of Neuroradiology 44 (12): 1451–57. doi:10.3174/ajnr.A8057.